284 |
My Experience Focusing on Cusp Overlap View |
Ju Han Kim |
Apr. 12. 21 |
283 |
How to Reduce PPI Rate with Cusp Overlap Technique |
Hemal Gada |
Apr. 12. 21 |
282 |
Antiplatelets Only Sufficient: TAVR Antithrombotics Less is More |
George D. Dangas |
Apr. 12. 21 |
281 |
Transcatheter Mitral Valve Repair: Guideline Changes, Evidence Gaps and Future Directions |
Gregg W. Stone |
Apr. 12. 21 |
280 |
TAVR Long Journey: Chain of RCTs, Guideline Changes, and Future Directions |
Martin Bert Leon |
Apr. 12. 21 |
279 |
Coronary Access Post TAVI |
Danny Dvir |
Apr. 12. 21 |
278 |
Minimizing Embolic Events: Latest TAVR Data |
Eberhard Grube |
Apr. 12. 21 |
277 |
New Insights from the COAPT: Patient Eligibility and Timing |
Gregg W. Stone |
Aug. 06. 20 |
276 |
Comparative Assessment of Aortic Regurgitation Post TAVR in (9) Commercially Available THV\'s |
Patrick W. Serruys |
Aug. 06. 20 |
275 |
The Future Trend in TAVR: The Remaining Hurdles |
Samir R. Kapadia |
Aug. 06. 20 |